Canary Staked INJ ETF (INJC) begins trading on Nasdaq
Nasdaq began listing Canary's Staked INJ ETF (ticker INJC) on November 5, 2026.
Nasdaq began listing the Canary Staked INJ ETF under ticker INJC on November 5, 2026. Canary Capital filed a Form 8-A on November 3 stating that Nasdaq had approved the listing application. Injective published a launch post the same day trading began.
Key facts
- Product: Canary Staked INJ ETF
- Ticker: INJC
- Listing approval filing: Form 8-A, November 3, 2026
- First trading day: November 5, 2026 (Nasdaq Trader Alert ETP2026-179)
- Aim: INJ price exposure, plus net staking rewards reflected in NAV (Injective)
- Lead market maker: Flow Traders U.S. LLC, per the Nasdaq alert
What the fund does
The trust holds Injective's INJ token. It also seeks to earn additional INJ through proof-of-stake validation, with net rewards reflected in net asset value. Canary's preliminary prospectus materials have described staking a large share of holdings under normal conditions, while keeping some INJ liquid for redemptions and expenses. Staking targets in a prospectus are not a promised yield.
Why it matters
INJC adds another US-listed product that combines spot crypto exposure with onchain staking. It sits alongside staked ETH products already in the market and shows how staking rewards are being packaged for brokerage accounts.